Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 02, 2016 | Ten Percent Owner | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | 15,876,947 | |
| Jun 27, 2007 | Senior VP, Drug Development | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | 48,866 | |
| Jun 06, 2007 | Ten Percent Owner | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | -- | |
| Jun 06, 2007 | Ten Percent Owner | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | -- | |
| Jun 06, 2007 | Ten Percent Owner | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | -- | |
| Jun 06, 2007 | Ten Percent Owner | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | -- | |
| Jun 06, 2007 | Ten Percent Owner | Amendment to an Initial Statement of Beneficial Ownership of Securities | Form 3/A | -- | -- | -- | |
| Jun 16, 2021 | Director, Chairman & CEO | Bona fide gift | Form 4 | 230,000 | -- | -- | |
| Jun 16, 2021 | Director, Chairman & CEO | Bona fide gift | Form 4 | 230,000 | -- | -- | |
| Jun 16, 2021 | Director, Chairman & CEO | Bona fide gift | Form 4 | 250,000 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.